about
Vitrification media: toxicity, permeability, and dielectric properties.The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.Human neutrophil elastase inhibitors in innate and adaptive immunity.Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.Inflammation-associated remodelling and fibrosis in the lung - a process and an end point.Effector and central memory T helper 2 cells respond differently to peptide immunotherapy.Respiratory and gastrointestinal epithelial modulation of the immune response during viral infection.Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.Chlamydia trachomatis and Chlamydophila abortus induce the expression of secretory leukocyte protease inhibitor in cells of the human female reproductive tract.Oxidative damage and TGF-β differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease.Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota.Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation.FITC-induced murine pulmonary inflammation: CC10 up-regulation and concurrent Shh expression.Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+CD25+Foxp3+ regulatory cells.Sonic Hedgehog Signaling Modulates Activation of and Cytokine Production by Human Peripheral CD4+ T Cells
P50
Q34133054-90A2B28A-CE8A-430C-A9E5-92B0C629BED9Q34983753-22562AEE-782F-44BF-9198-AFA35BB85FF0Q36424323-5BE3E11D-CCA6-4A37-92A0-B307D7AB89AFQ36650606-63FD5B51-FBEA-44F8-AC9E-EC2116D14D11Q36780178-3F5B2B0B-D234-428A-B694-40A404CE89A2Q37612747-AFC7FE45-B4C1-443D-999A-DC56D3DA0875Q37829145-579597AB-BCCE-4229-AAC6-E96B23E83624Q37852394-A6FADC2F-DB55-4560-81A0-EB01FF929CC3Q37856114-77D2B7B3-71E1-4CB5-B8A1-CD3C7E0CEE08Q38413953-EA673B7D-9D44-49EE-8B32-213895FB5177Q38961697-9E30EE58-15AF-47A4-8B22-65ED44148B86Q39527744-6F2F8429-A853-4B88-880A-6DA9F7E799C2Q46693315-F0324F3C-A085-47AA-899A-353F23B1E6FAQ46915110-52369532-2629-4FF2-9CB5-65355F074278Q61971099-BBD57E0A-86DA-485E-A638-B33FE30A8550
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul M Fitch
@ast
Paul M Fitch
@en
Paul M Fitch
@es
Paul M Fitch
@nl
type
label
Paul M Fitch
@ast
Paul M Fitch
@en
Paul M Fitch
@es
Paul M Fitch
@nl
prefLabel
Paul M Fitch
@ast
Paul M Fitch
@en
Paul M Fitch
@es
Paul M Fitch
@nl
P106
P31
P496
0000-0001-5294-3340